AARP, Medicare

New AARP Report: Top Medicare Part D Drugs See Average Lifetime Price Hike of 98%
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included in the historic 2022 drug law.
Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.
Medicare drug prices nearly double, surpassing inflation: AARP
A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly doubled in price since market entry, exceeding inflation trends. Yahoo Finance senior health reporter Anjalee Khemlani joins Brad Smith on Wealth to discuss the findings,
25 Top Medicare Part D Drugs Have Nearly Doubled in Price
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit, enrollees are responsible for 25 percent of their dr
Report: Prices for top Medicare Part D drugs nearly doubled since entering the market
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by the AARP Public Policy Institute.
Part D Drugs Almost Doubled in Cost Since Launch, Underscoring Importance of IRA: AARP
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into small-molecule drug development.
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday. The report from AARP Public Policy Institute said average list prices on these 25 drugs have nearly doubled since they hit the market and collectively cost Medicare ‒ and American taxpayers ‒ nearly $50 billion in 2022.
Pharma companies welcome new year with 583 drug price hikes so far
Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, 46brooklyn Research, an Ohio non-profit focused on U.S. drug pricing data, said in a report on Thursday.
KSTP-TV45m
Change in Medicare prescription drug coverage will help millions
There’s a major change in 2025 to Medicare’s prescription drug coverage. This year, there’s a new $2,000 cap on annual out-of ...
AARP1d
AARP Bulletin: Health Care Systems Under Duress, What to Do After a Data Breach, and Tips for Flying with a Medical Device
The first issue of AARP Bulletin in 2025 examines the physician shortage crisis and what it means for older adults. Additionally, this month’s issue provides insights on how to handle data breaches, ...
Medicare caps seniors drug expenses: What you need to know
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
valuepenguin4d
AARP Medicare Supplement Review 2025: Cheap Rates, Great Perks
AARP/UnitedHealthcare Medigap costs an average of $158 per month for Plan G and comes with impressive benefits. AARP Medicare Supplement plans are a good option if you want extra perks. The ...
Medicare's new $2,000 prescription drug cap goes into effect. Here's how it works.
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...
AARP Virginia to advocate for lower prescription costs, nursing home reform
State Advocacy Director Jared Calfee said the organization plans to push for legislation supporting efforts like lowering ...